Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Valproic acid 500mg gastro-resistant capsules
040801020AAACAC
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 2,770 |
|
Valproic acid 300mg gastro-resistant capsules
040801020AAABAB
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 834 |
|
Valproic acid 150mg gastro-resistant capsules
040801020AAAAAA
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 387 |
|
Valproic acid 500mg/5ml oral liquid
040801020AAAGAG
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 21 |
|
Valproic acid 125mg gastro-resistant capsules
040801020AAAHAH
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | No data available |
|
Valproic acid 250mg/5ml oral liquid
040801020AAAFAF
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.